225Ac-DOTA-SP (TAT)

Actinium-225-DOTA-SP · Medical University of Warsaw

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 225Ac-DOTA-SP (TAT), covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4) [NA]